JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic
Executive Summary
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.
You may also be interested in...
Integra LifeSciences Returns To Organic Growth After Rough Year With COVID-19
Integra's first-quarter revenue was up less than 3%, year over year, but the company reported the integration of the ACell regenerative technology business is ahead of schedule
Integra Adds ACell’s Regenerative Tech As It Dumps Extremity Orthopedics
Integra will pay up to $400m for ACell to expand its wound management and soft-tissue repair product line. The deal is part of a larger restructuring plan that includes selling its orthopedics business.
CMS Final Medicare Outpatient Rule Gives Patients More Surgical Site Choices, At Lower Costs
The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.